ArticleCommunications biology2025
Brain insulin receptor gene network shapes risk for metabolic disease after early-life stress in women.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Stress happening during critical periods of development shapes individual physiology and increases the risk for obesity, inflammatory, and metabolic disturbances throughout life. However, there are individual differences and not everyone exposed to stress or adversity early during development develops chronic adult disease. Insulin regulates peripheral glucose metabolism, acts as a neuromodulator in the brain, and is possibly implicated in individual differences in response to early adversity. Expression-based polygenic scores (ePRS) reflect variations in the expression of a tissue-specific gene co-expression network. We have previously shown that brain-based insulin receptor ePRS (ePRS-IR) can identify risk for metabolic and frailty outcomes in older adults. Here, we show that the mesocorticolimbic ePRS-IR moderates the association between early adversity and increased visceral adipose tissue as well as metabolic syndrome in a large sample of adult women (UK Biobank). These findings suggest that variations in the function of the brain insulin receptor network influence the susceptibility to the long-term effects of adversity, highlighting a target system for prevention and novel treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.